Plus Therapeutics Ownership | Who Owns Plus Therapeutics?


OverviewForecastRevenueFinancialsChart

Plus Therapeutics Ownership Summary


Plus Therapeutics is owned by 7.41% institutional investors, 1.45% insiders, and 91.14% retail investors. Geode capital management is the largest institutional shareholder, holding 2.59% of PSTV shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.41% of its assets in Plus Therapeutics shares.

PSTV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPlus Therapeutics7.41%1.45%91.14%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management2.02M2.59%$327.98K
Blackrock funding, inc. /de1.78M2.28%$288.84K
Vanguard group2.28M2.12%$1.17M
Vanguard fiduciary trust1.16M1.50%$189.69K
State street468.89K0.60%$76.24K
Northern trust293.30K0.38%$47.69K
Millennium management271.60K0.35%$44.16K
Scientech research146.65K0.30%$100.27K
Two sigma securities142.81K0.18%$23.22K
Xtx topco116.02K0.15%$18.86K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Scientech research146.65K0.03%$100.27K
Miller financial services50.00K0.01%$8.13K
Two sigma securities142.81K0.00%$23.22K
Dagco25.88K0.00%$4.21K
Xtx topco116.02K0.00%$18.86K
Ashton thomas private wealth32.91K0.00%$5.35K
Tower research capital llc (trc)3.52K0.00%$2.41K
Atlantic union bankshares---
Jane street group---
Advisor group133.00-$21.00

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust1.16M-1.16M
Vanguard group2.28M-832.59K
Geode capital management2.02M-613.52K
Millennium management271.60K-271.60K
Scientech research146.65K0.03%146.65K

Top Sellers

HolderShares% AssetsChange
Jane street group---1.02M
Altium capital management lp---918.91K
Ubs group87.85K--788.00K
Virtu financial---496.76K
Citadel advisors---185.06K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust1.16M-1.16M$189.69K
Millennium management271.60K-271.60K$44.16K
Scientech research146.65K0.03%146.65K$100.27K
Vanguard global advisers57.07K-57.07K$9.30K
Miller financial services50.00K0.01%50.00K$8.13K

Sold Out

HolderChange
Danske bank-1.00
Group one trading-1.00
Barclays-2.00
Jones financial companies lllp-26.00
Tradewinds capital management-200.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202614-48.15%5,763,292-50.12%76.40%7-65.00%1-
Dec 31, 202519-17.39%10,271,35596.96%98.23%13-35.00%1-50.00%
Sep 30, 20252335.29%5,214,8311279.19%10159.96%2081.82%2-33.33%
Jun 30, 2025176.25%378,108-2.84%25.96%1110.00%350.00%
Mar 31, 20251660.00%389,160-42.62%64.99%10150.00%2-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr97.07K1.41%-2.33M
Fidelity Extended Market Index1.08M0.63%352.81K
Abante Quant Value FI514.25K0.30%-
Extended Equity Market Fund E462.94K0.27%-
Extended Equity Market Fund B462.94K0.27%-
Blackrock Extended Mkt Fund CF18.52K0.27%-444.43K
Extended Equity Market Fund K394.18K0.23%-2.89K
BlackRock Extended Equity Market Fund K394.18K0.23%-2.89K
Fidelity Series Total Market Index258.32K0.15%65.76K
Fidelity Total Market Index249.15K0.15%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 04, 2025Sims Andrew John Hugh MacIntyre Chief Financial OfficerBuy$10.20K
Aug 22, 2025Lenk Robert P-Buy$53.78K
Sep 13, 2024Hawkins Richard J-Buy$6.00K
Sep 12, 2024Hawkins Richard J-Buy$8.51K
Sep 11, 2024Petersen Greg-Buy$16.88K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q41-
2025 Q31-
2025 Q2--

PSTV Ownership FAQ


Who Owns Plus Therapeutics?

Plus Therapeutics shareholders are primarily institutional investors at 7.41%, followed by 1.45% insiders and 91.14% retail investors. The average institutional ownership in Plus Therapeutics's industry, Biotech Stocks , is 35.75%, which Plus Therapeutics falls below.

Who owns the most shares of Plus Therapeutics?

Plus Therapeutics’s largest shareholders are Geode capital management (2.02M shares, 2.59%), Blackrock funding, inc. /de (1.78M shares, 2.28%), and Vanguard group (2.28M shares, 2.12%). Together, they hold 7.00% of Plus Therapeutics’s total shares outstanding.

Does Blackrock own Plus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Plus Therapeutics.

Who is Plus Therapeutics’s biggest shareholder by percentage of total assets invested?

Scientech research is Plus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 146.65K Plus Therapeutics shares, valued at 100.27K$.

Who is the top mutual fund holder of Plus Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Plus Therapeutics shares, with 1.41% of its total shares outstanding invested in 97.07K Plus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools